0001656472-21-000027.txt : 20210304
0001656472-21-000027.hdr.sgml : 20210304
20210304173944
ACCESSION NUMBER: 0001656472-21-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210302
FILED AS OF DATE: 20210304
DATE AS OF CHANGE: 20210304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GORENSTEIN MICHAEL RYAN
CENTRAL INDEX KEY: 0001797199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38403
FILM NUMBER: 21715525
MAIL ADDRESS:
STREET 1: 111 PETER STREET, SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cronos Group Inc.
CENTRAL INDEX KEY: 0001656472
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
BUSINESS PHONE: (416) 504-0004
MAIL ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaCan Capital Corp.
DATE OF NAME CHANGE: 20151021
4
1
wf-form4_161489756357507.xml
FORM 4
X0306
4
2021-03-02
0
0001656472
Cronos Group Inc.
CRON
0001797199
GORENSTEIN MICHAEL RYAN
111 PETER STREET, SUITE 300
TORONTO
A6
M5V 2H1
ONTARIO, CANADA
1
1
0
0
Executive Chairman
COMMON SHARES
2021-03-02
4
M
0
487500
0.3938
A
4999796
D
COMMON SHARES
2021-03-02
4
F
0
143485
11.0014
D
4856311
D
COMMON SHARES
2021-03-02
4
M
0
3990221
0.1929
A
8846532
D
COMMON SHARES
2021-03-02
4
F
0
69981
11.0014
D
8776551
D
COMMON SHARES
2021-03-02
4
S
0
230000
11.0458
D
8546551
D
COMMON SHARES
2021-03-03
4
S
0
114015
10.3869
D
8432536
D
COMMON SHARE OPTION (right to buy)
0.3938
2021-03-02
4
M
0
487500
0
D
2021-08-05
COMMON SHARES
487500.0
0
D
WARRANTS
0.1929
2021-03-02
4
M
0
3990221
0
D
2021-05-27
COMMON SHARES
3990221.0
0
D
The price reported was converted from the Canadian exercise price of C$0.50 to U.S. dollars using an exchange rate of C$1.00 to US$0.7875 as reported by Bloomberg as of March 1, 2021.
Cronos Group Inc. (the "Company") withheld 143,485 common shares underlying the options for payment of the exercise price and to cover applicable withholding taxes, using the closing price of the Company's common shares on March 1, 2021 of C$13.97 as reported on the Toronto Stock Exchange.
The price reported is in U.S. dollars based on the exchange rate of C$1.00 to US$0.7875 as reported by Bloomberg as of March 1, 2021.
The price reported was converted from the Canadian exercise price of C$0.245 to U.S. dollars using an exchange rate of C$1.00 to US$0.7875 as reported by Bloomberg as of March 1, 2021.
On March 2, 2021, the reporting person exercised warrants to purchase 3,990,221 common shares of the Company for C$0.245 per common share. The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 69,981 common shares to pay the exercise price and issuing to the reporting person the remaining 3,920,240 common shares.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.715 to $11.37, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) and footnote (7) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.23 to $10.5901, inclusive.
The options were granted August 5, 2016 and vested in monthly installments over a four-year period.
The warrants were issued between May 16, 2016 and August 12, 2016 and were immediately exercisable.
/s/ Eileen Uy, as attorney-in-fact for Michael R. Gorenstein
2021-03-04